Arnold B. Etame, MD, PhD

Where You Are:

Arnold B. Etame, MD, PhD

Neurosurgery

 
 

BOARD CERTIFICATION:
          •  Neurological Surgery

FELLOWSHIP:
          •  Labbatt Brain Tumor Centre, Hospital for Sick Children, Toronto - Neurosurgery Oncology

RESIDENCY:
          •  University of Michigan Medical Center - Neurosurgery

MEDICAL SCHOOL:
          •  University of Iowa College of Medicine - MD

  • Diaz RJ, McVeigh PZ, O'Reilly MA, Burrell K, Bebenek M, Smith C, Etame A, Zadeh G, Hynynen K, Wilson BC, Rutka JT. Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier: Potential for targeting experimental brain tumors. Nanomedicine. 2014 Jul;10(5):1075-1087. Pubmedid: 24374363. Pmcid: PMC4074278.

  • Kaloostian PE, Zadnik PL, Etame AB, Vrionis FD, Gokaslan ZL, Sciubba DM. Surgical management of primary and metastatic spinal tumors. Cancer Control. 2014 Apr;21(2):133-139. Pubmedid: 24667399.

  • Kaloostian PE, Yurter A, Etame AB, Vrionis FD, Sciubba DM, Gokaslan ZL. Palliative strategies for the management of primary and metastatic spinal tumors. Cancer Control. 2014 Apr;21(2):140-143. Pubmedid: 24667400.

  • Ahmed KA, Sarangkasiri S, Chinnaiyan P, Sahebjam S, Yu HH, Etame AB, Rao NG. Outcomes Following Hypofractionated Stereotactic Radiotherapy in the Management of Brain Metastases. Am J Clin Oncol. 2014 Apr. Pubmedid: 24755663.

  • Etame AB, Bentley JN, Pandey AS. Acute expansion of an asymptomatic posterior communicating artery aneurysm resulting in oculomotor nerve palsy. BMJ Case Rep. 2013 Jun;2013. Pubmedid: 23761613.

  • Niknafs YS, Wang AC, Than KD, Etame AB, Thompson BG, Sullivan SE. Hemorrhagic Vestibular Schwannoma: Review of the Literature. World Neurosurg. 2013 Feb. Pubmedid: 23454397.

  • Etame AB, Diaz RJ, O'Reilly MA, Smith CA, Mainprize TG, Hynynen K, Rutka JT. Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. Nanomedicine. 2012 Oct;8(7):1133-1142. Pubmedid: 22349099.

  • Etame AB, Smith CA, Chan WC, Rutka JT. Design and potential application of PEGylated gold nanoparticles with size-dependent permeation through brain microvasculature. Nanomedicine. 2012 Mar;7(6):992-1000. Pubmedid: 21616168.

  • Sagher O, Thawani JP, Etame AB, Gomez-Hassan DM. Seizure outcomes and mesial resection volumes following selective amygdalohippocampectomy and temporal lobectomy. Neurosurg Focus. 2012 Mar;32(3):E8. Pubmedid: 22380862.

  • Etame AB, Diaz RJ, Smith CA, Mainprize TG, Hynynen K, Rutka JT. Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology. Neurosurg Focus. 2012 Jan;32(1):E3. Pubmedid: 22208896.

  • Etame AB, Fox WC, Sagher O. Osmotic diuresis paradoxically worsens brain shift after subdural grid placement. Acta Neurochir (Wien). 2011 Mar;153(3):633-637. Pubmedid: 21057826.

  • Onvani S, Etame AB, Smith CA, Rutka JT. Genetics of medulloblastoma: clues for novel therapies. Expert Rev Neurother. 2010 May;10(5):811-823. Pubmedid: 20420498.

  • Etame AB, Wang AC, Than KD, La Marca F, Park P. Outcomes after surgery for cervical spine deformity: review of the literature. Neurosurg Focus. 2010 Mar;28(3):E14. Pubmedid: 20192659.

  • Wang AC, Than KD, Etame AB, La Marca F, Park P. Impact of anesthesia on transcranial electric motor evoked potential monitoring during spine surgery: a review of the literature. Neurosurg Focus. 2009 Oct;27(4):E7. Pubmedid: 19795956.

  • Sack JA, Etame AB, Shah GV, La Marca F, Park P. Management and outcomes of patients undergoing surgery for traumatic cervical fracture-subluxation associated with an asymptomatic vertebral artery injury. J Spinal Disord Tech. 2009 Apr;22(2):86-90. Pubmedid: 19342928.

  • Than KD, Wang AC, Etame AB, La Marca F, Park P. Postoperative management of incidental durotomy in minimally invasive lumbar spinal surgery. Minim Invasive Neurosurg. 2008 Oct;51(5):263-266. Pubmedid: 18855289.

  • Etame AB, Than KD, Wang AC, La Marca F, Park P. Surgical management of symptomatic cervical or cervicothoracic kyphosis due to ankylosing spondylitis. Spine (Phila Pa 1976). 2008 Jul;33(16):E559-E564. Pubmedid: 18628698.

  • Sibenaller ZA, Etame AB, Ali MM, Barua M, Braun TA, Casavant TL, Ryken TC. Genetic characterization of commonly used glioma cell lines in the rat animal model system. Neurosurg Focus. 2005 Oct;19(4):E1. Pubmedid: 16241103.

Dr. Arnold Etame is a Neurological Surgeon and Scientist specializing in Neuro-Oncology at the Moffitt Cancer Center, and Assistant Professor of Oncology at the University of South Florida, College of Medicine.  He performs a substantial number of surgeries in eloquent and non-eloquent regions of the brain with image-guided stereotactic techniques entailing functional MRI and DTI tractography neuro-navigation.  He also directs a very active awake-brain tumor resection program for patients with tumors close to critical areas for speech and movement. In collaboration with Dr. Rao of Radiation Oncology, he co-directs the stereotactic radiosurgery program for brain and spine metastatic tumors.  His research focuses on enhanced delivery of targeted therapeutics across the blood-brain barrier for malignant and metastatic brain tumors using nanotechnology and focused ultrasound disruption of the blood-brain barrier.  He is a principal investigator for clinical trial protocols in patients with malignant brain tumors. He will be leading a Phase III vaccine trial for patients with glioblastoma multiforme (GBM).

Dr. Etame received his BS degree in Chemistry Magna Cum Laude from the State University New York at New Paltz.  He subsequently completed his MD degree with Distinction in Research from the University of Iowa College of Medicine where he was elected to the Alpha Omega Alpha Honor Medical Society, and the Gold Humanism Medical Society.  His Neurosurgery Specialization was completed at the University of Michigan. Under the mentorship of renowned neurosurgeon and scientist - Dr. James Rutka – Dr Etame was awarded a Neuro-oncology Research Fellowship with the Labatt Brain Tumour Research Centre at the Hospital for Sick Children in Toronto, Canada.  During this time, Dr Etame also pursued and completed his PhD in the Department of Laboratory Medicine and Pathobiology at the University of Toronto.  His work focused on optimizing nanoparticle-based delivery strategies across the blood-brain barrier for subsequent targeting of invasive pathways in malignant gliomas. He has received numerous awards including the prestigious Wilder Penfield Fellowship Award from the Congress of Neurological Surgeons.  He has authored several peer-reviewed publications and book chapters.

He is a member of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS).

Check out my recent articles in OncLive:

Neurosurgical Innovations Advance Safe Resection of Difficult Brain Tumors

The Awake Craniotomy Presents Advantages in Resection of Eloquent Cortex Brain Tumors

How I Treat Patients with Surgically Resectable Brain Cancers 

TOOLS:   Font Size small font resizer separator font resizer separator big font resizer